TY  - JOUR
T1  - The Frequency of Nonalcoholic Fatty Liver Disease (NAFLD) in Type 2 Diabetes Mellitus
AU - Desai, Jabbar AU - Patil, V.C. AU - Botre, Amite AU - Mane, U.T. AU - Kapale, R.J. 
JO  - International Journal of Tropical Medicine
VL  - 11
IS  - 6
SP  - 281
EP  - 283
PY  - 2016
DA  - 2001/08/19
SN  - 1816-3319
DO  - ijtmed.2016.281.283
UR  - https://makhillpublications.co/view-article.php?doi=ijtmed.2016.281.283
KW  - Nonalcoholic fatty liver disease
KW  -Type 2 diabetes mellitus
KW  -liver disease
KW  -nonalcoholic
KW  -NAFLD
AB  - The most frequent source of impaired liver
function tests in adults is Nonalcoholic Fatty Liver
Disease (NAFLD). Type 2 Diabetes Mellitus (DM) and
Non-Alcoholic Liver Fatty Disease (NAFLD) are usually
seen together. It was considered a manifestation of
metabolic syndrome. NAFLD’s symptoms vary from
basic steatose (NAFL), Non-Alcoholic Steatohepatitis
(NASH) and cirrhosis. The prevalence of NAFLD among
T2DM patients is 70%. This was a hospital based study.
The study lacks histological evidence for NAFLD in the
cases included and enhanced imaging modality such as
MRI spectroscopy was not included in the treatment of
NAFLD in this research. NAFLD is particularly prevalent
in person with type 2 diabetes and is correlated with high
CVD prevalence.
ER  -